NCT01144442 WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer Status TERMINATED Phase NA
NCT01133756 E7080 in Combination With Carboplatin + Gemcitabine Versus Carboplatin + Gemcitabine Alone as Second Line Therapy in Patients With Platinum-Sensitive Recurrent Ovarian Cancer by CA125 Status TERMINATED Phase PHASE1/PHASE2
NCT01110603 A Study of MK-4827 in Combination With Standard Chemotherapy in Participants With Advanced Solid Tumors (MK-4827-008 AM1) Status TERMINATED Phase PHASE1
NCT01107626 Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT01100931 A Phase I/II Study of Paclitaxel, Carboplatin and YM155 (Survivin Suppressor) in Subjects With Solid Tumors (Phase I) and Advanced Non-Small Cell Lung Carcinoma (Phase II) Status COMPLETED Phase PHASE1/PHASE2
NCT01100359 Liposome-Encapsulated Doxorubicin Citrate and Carboplatin in Treating Patients With Advanced or Metastatic Recurrent Endometrial Cancer Status UNKNOWN Phase PHASE2
NCT01097746 First-Line Treatment of Bevacizumab, Carboplatin, and Paclitaxel in Treating Participants With Stage III-IV Ovarian, Primary Peritoneal, and Fallopian Tube Cancer Status COMPLETED Phase PHASE2
NCT01097317 First-Line Chemotherapy With or Without Neuromuscular Electrical Stimulation in Treating Patients With Non-Small Cell Lung Cancer Status UNKNOWN Phase PHASE2
NCT01097057 Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Autologous Peripheral Blood Stem Cells Status COMPLETED Phase PHASE2
NCT01096368 Maintenance Chemotherapy or Observation Following Induction Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Ependymoma Status COMPLETED Phase PHASE3
NCT01088802 Treatment De-Intensification for Squamous Cell Carcinoma of the Oropharynx Status COMPLETED Phase PHASE2
NCT01088035 Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma Status TERMINATED Phase PHASE2
NCT01087970 A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer Status COMPLETED Phase PHASE2
NCT01081951 Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01081262 Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01076504 A Trial of Amrubicin and Carboplatin With Pegfilgrastim in Patients With Extensive-Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2